BB Biotech AG BBAGF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/15/24 EDT
56.76UNCH (UNCH)
52 week range
43.65 - 57.70
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close56.76
  • 52 Week High57.70
  • 52 Week High Date01/16/24
  • 52 Week Low43.65
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap2,876.68M
  • Shares Out54.85M
  • 10 Day Average Volume1
  • Dividend2.21
  • Dividend Yield3.90%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close56.76
  • 52 Week High57.70
  • 52 Week High Date01/16/24
  • 52 Week Low43.65
  • 52 Week Low Date10/04/23
  • Market Cap2,876.68M
  • Shares Out54.85M
  • 10 Day Average Volume1
  • Dividend2.21
  • Dividend Yield3.90%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-4.47
  • P/E (TTM)-12.69
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/25/2024
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest On BB Biotech AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk...
Erich Hunziker Ph.D.
Independent Chairman of the Board
Address
Schwertstrasse 6
Schaffhausen
8200
Switzerland